CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- 4 Planned sale Chief Financial Officer sold 7,231 shares at $3.55 ($25,670)
- 4 Planned sale Chief Legal Officer sold 13,761 shares at $3.55 ($48,852)
- 4 Planned sale Chief Operating Officer sold 25,874 shares at $3.48 ($90,042)
- 4 Planned sale Chief Technology Officer sold 8,168 shares at $3.48 ($28,425)
- 4 Planned sale EVP, Operations & R&D sold 2,869 shares at $3.70 ($10,615)
- 4 Planned sale President and CEO sold 29,244 shares at $3.70 ($108,203)
- 4 Option exercise Chief Technology Officer acquired 21,270 shares (option exercise)
- 4 Grant or award Chief Technology Officer acquired 64,915 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 115,920 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 127,512 shares (grant or award)
- 4 Grant or award President and CEO acquired 154,560 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 86,940 shares (grant or award)
- 4 Grant or award EVP, Operations & R&D acquired 100,464 shares (grant or award)
- 4 Planned sale Chief Technology Officer sold 4,836 shares at $6.62 ($32,014)
- 4 Planned sale Chief Financial Officer sold 2,616 shares at $6.62 ($17,318)
- 4 Planned sale President and CEO sold 22,362 shares at $6.62 ($148,036)
- 4 Planned sale Chief Legal Officer sold 6,308 shares at $6.62 ($41,759)
- 4 Open-market sale President and CEO sold 37,226 shares at an average $7.45 ($277,183)
- 4 Planned sale Chief Legal Officer sold 11,170 shares at an average $7.77 ($86,743)
- 4 Open-market sale Chief Technology Officer sold 9,660 shares at an average $7.57 ($73,148)
Page 2 of 12 · 225 filings